Skip to main content
Top
Published in: Abdominal Radiology 12/2021

01-12-2021 | Hysterectomy | Interventional Radiology

Ovarian arteries embolization in women with persistent symptoms following uterine arteries embolization for uterus fibroids

Authors: Héloïse Ifergan, Thomas Perus, Kevin Janot, Basile Kerleroux, Jonathan Ifergan, Richard Bibi, Henri Marret, Grégoire Boulouis, Henri Azaïs, Denis Herbreteau

Published in: Abdominal Radiology | Issue 12/2021

Login to get access

Abstract

Purpose

In patients with persisting symptoms after uterine arteries embolization (UAE), ovarian arteries embolization (OAE) may play a role to improve symptoms and decrease subsequent surgery rates. In a retrospective cohort, we aimed to investigate the efficacy and safety of OAE in females with recurrent or persistent symptoms following UAE.

Methods

We performed a retrospective analysis of prospectively collected cases at a single reference academic hospital; we identified patients who benefited from OAE for persisting symptoms following UAE from 2008 to 2021. Outcome variables included the rates of subsequent surgery, a quality-of-life questionnaire with the UFS-QOL tool, the MRI reduction in uterine and fibroids volumes and the fibroid devascularization rate.

Results

Among 1300 women treated with UAE during the study period, 18 eventually received OAE and were included (mean age 44 ± 4.3 SD). There was no OAE procedural complication.
There was a decrease in uterine volume and a complete devascularization of the dominant fibroid in 10/11 (90.9%) patients who underwent 12 months MRI. Three women underwent subsequent hysterectomy. Among 10/18 patients who answered the quality-of-life questionnaire after a mean follow-up of 70 months, eight reported an improvement or stability of symptoms.

Conclusion

OAE for persisting symptoms after UAE was associated with improvement or stability of quality-of-life in most study subjects and less than a fifth of the cohort underwent hysterectomy after OAE. This study highlights the role of OAE as an adjunct to UAE.

Graphic abstract

Literature
4.
go back to reference Kisilevzky N Kisilevzky Nestor. Uterine embolization for management of symptomatic fibroids: quality-of-life impact. Radiol Bras [Internet]. 2007 Oct [cited 2021 Feb 05] ; 40( 5 ): 289-296. 8CrossRef Kisilevzky N Kisilevzky Nestor. Uterine embolization for management of symptomatic fibroids: quality-of-life impact. Radiol Bras [Internet]. 2007 Oct [cited 2021 Feb 05] ; 40( 5 ): 289-296. 8CrossRef
7.
go back to reference Goodwin, S. C., Spies, J. B., Worthington-Kirsch, R., Peterson, E., Pron, G., Li, S., Myers, E. R., & Fibroid Registry for Outcomes Data (FIBROID) Registry Steering Committee and Core Site Investigators (2008). Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstetrics and gynecology, 111(1), 22–33. doi:https://doi.org/10.1097/01.AOG.0000296526.71749.c9CrossRefPubMed Goodwin, S. C., Spies, J. B., Worthington-Kirsch, R., Peterson, E., Pron, G., Li, S., Myers, E. R., & Fibroid Registry for Outcomes Data (FIBROID) Registry Steering Committee and Core Site Investigators (2008). Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstetrics and gynecology, 111(1), 22–33. doi:https://​doi.​org/​10.​1097/​01.​AOG.​0000296526.​71749.​c9CrossRefPubMed
11.
go back to reference Pelage JP, Walker WJ, Le Dref O, Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc Intervent Radiol. 2003 May-Jun;26(3):227-33.CrossRef Pelage JP, Walker WJ, Le Dref O, Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc Intervent Radiol. 2003 May-Jun;26(3):227-33.CrossRef
12.
go back to reference Razavi MK, Wolanske KA, Hwang GL, Sze DY, Kee ST, Dake MD. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology. 2002; 224:707–712.CrossRef Razavi MK, Wolanske KA, Hwang GL, Sze DY, Kee ST, Dake MD. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology. 2002; 224:707–712.CrossRef
13.
go back to reference Barth MM, Spies JB. Ovarian artery embolization supplementing uterine embolization for leiomyomata. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1177-82.CrossRef Barth MM, Spies JB. Ovarian artery embolization supplementing uterine embolization for leiomyomata. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1177-82.CrossRef
14.
go back to reference Hu NN, Kaw D, McCullough MF, Nsouli-Maktabi H, Spies JB. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol. 2011 May;22(5):710-715.e1.CrossRef Hu NN, Kaw D, McCullough MF, Nsouli-Maktabi H, Spies JB. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol. 2011 May;22(5):710-715.e1.CrossRef
15.
go back to reference Campbell J, Rajan DK, Kachura JR, et al. Efficacy of ovarian artery embolization for uterine fibroids: clinical and magnetic resonance imaging evaluations. Can Assoc Radiol J. 2015 May;66(2):164-70.CrossRef Campbell J, Rajan DK, Kachura JR, et al. Efficacy of ovarian artery embolization for uterine fibroids: clinical and magnetic resonance imaging evaluations. Can Assoc Radiol J. 2015 May;66(2):164-70.CrossRef
17.
go back to reference Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002 Feb;99(2):290-300.PubMed Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002 Feb;99(2):290-300.PubMed
20.
go back to reference Kozik W, Czerwiński F, Pilarczyk K, Partyka C. Arteries of the hilum and parenchymal part of the ovary in reproductive age in microangiographic studies. Ginekol Pol. 2002 Dec;73(12):1173-8.PubMed Kozik W, Czerwiński F, Pilarczyk K, Partyka C. Arteries of the hilum and parenchymal part of the ovary in reproductive age in microangiographic studies. Ginekol Pol. 2002 Dec;73(12):1173-8.PubMed
25.
go back to reference The French Society of Interventional and cardiovascular Imaging (SFICV) research group, Kovacsik HV, Herbreteau D, et al (2017) Evaluation of Changes in Sexual Function Related to Uterine Fibroid Embolization (UFE): Results of the EFUZEN Study. Cardiovasc Intervent Radiol 40:1169–1175. doi:https://doi.org/10.1007/s00270-017-1615-3CrossRef The French Society of Interventional and cardiovascular Imaging (SFICV) research group, Kovacsik HV, Herbreteau D, et al (2017) Evaluation of Changes in Sexual Function Related to Uterine Fibroid Embolization (UFE): Results of the EFUZEN Study. Cardiovasc Intervent Radiol 40:1169–1175. doi:https://​doi.​org/​10.​1007/​s00270-017-1615-3CrossRef
Metadata
Title
Ovarian arteries embolization in women with persistent symptoms following uterine arteries embolization for uterus fibroids
Authors
Héloïse Ifergan
Thomas Perus
Kevin Janot
Basile Kerleroux
Jonathan Ifergan
Richard Bibi
Henri Marret
Grégoire Boulouis
Henri Azaïs
Denis Herbreteau
Publication date
01-12-2021
Publisher
Springer US
Keyword
Hysterectomy
Published in
Abdominal Radiology / Issue 12/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03255-w

Other articles of this Issue 12/2021

Abdominal Radiology 12/2021 Go to the issue

Special Section: Young Professionals in Abdominal Radiology: Perspectives

Mosaic mentoring: finding the right mentor for the issue at hand

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.